Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 15 , ISSUE 1 ( January-February, 2023 ) > List of Articles

REVIEW ARTICLE

Hypoactive Sexual Desire Disorder (HSDD) in Women

Urvashi

Keywords : Female sexual dysfunction, Genito-pelvic dysesthesia

Citation Information : Urvashi. Hypoactive Sexual Desire Disorder (HSDD) in Women. J South Asian Feder Obs Gynae 2023; 15 (1):108-110.

DOI: 10.5005/jp-journals-10006-2172

License: CC BY-NC 4.0

Published Online: 19-04-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Female sexual dysfunction is a less discussed entity, which is difficult to screen or identify and treat as compared to male sexual dysfunction like erectile dysfunction, which is easy to diagnose and treat. Postmenopausal females with decreased sexual desire can be improved moderately by testosterone therapy. Genito-pelvic dysesthesia (GPD) is poorly understood. Hence, it requires a multidisciplinary biopsychosocial approach to identify the condition and thereby managing it. Managing the end organ, neurologic, pharmacological, vascular and emotional components improve the morbidity of affected ones. This will somehow prevent the patients from distress and life threatening consequences. In present scenario direct communication followed by assessment and thereby formulating the essential guidelines for treatment is on emphasis. The gap is being tried to be narrowed by more studies in this field. Topical sildenafil ointment under trail phase 2b results-eagerly awaited, Flibanserin- an oral medication, bremelanotide- an injectable are new to this field. Also the hormonal therapy along with the cognitive behavioral therapy is on research and trying to decrease the suffering from sexual or arousal disorders in coming eras.


PDF Share
  1. Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Sex Med 2019;16:1331–1337. DOI: 10.1080/13697137.2019.1637079.
  2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Female sexual dysfunction: ACOG Practice Bulletin clinical management guidelines for obstetrician-gynecologists, Number 213. Obstet Gynecol 2019;134:e1–e18. DOI: 10.1097/AOG.0000000000003324.
  3. Leiblum S, Seehuus M, Goldmeier D, et al. Psychological, medical, and pharmacological correlates of persistent genital arousal disorder. J Sex Med 2007;4:1358–1366.
  4. Fooladi E, Reuter SE, Bell RJ, et al. Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women. Menopause. 2015;22:44–49. DOI: 10.1097/GME.0000000000000259.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.